Search results (1331)
« Back to PublicationsResults of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting (vol 179, pg 471, 2017)
Eyre TA. et al, (2018), BRITISH JOURNAL OF HAEMATOLOGY, 180, 309 - 309
Surgical and Medical Management of Epithelial Ovarian Cancer
Fotopoulou C. et al, (2018), Dewhurst's Textbook of Obstetrics & Gynaecology, 884 - 904
The cost-effectiveness of immediate treatment or watch and wait with deferred chemotherapy for advanced asymptomatic follicular lymphoma.
Prettyjohns M. et al, (2018), Br J Haematol, 180, 52 - 59
A Single-Cell Approach to Unraveling Abnormal Megakaryocyte Differentiation and Function in Myelofibrosis
Psaila B. et al, (2017), BLOOD, 130
Cell-Intrinsic Depletion of AML1-ETO-Positive Pre-Leukemic HSCs By Kras Activating Mutation
Di Genua C. et al, (2017), BLOOD, 130
Molecular and Functional Characterization of Disease-Propagating Stem Cells in Juvenile Myelomonocytic Leukemia
Louka E. et al, (2017), BLOOD, 130
Unravelling Cell Cycle and Ontogeny Transcriptional Heterogeneity in Hematopoietic Stem Cells through Integrated Single Cell RNA-Seq
Povinelli B. et al, (2017), BLOOD, 130
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
Weber J. et al, (2017), N Engl J Med, 377, 1824 - 1835
Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two Phase 1 trials
Carvajal R. et al, (2017), JOURNAL FOR IMMUNOTHERAPY OF CANCER, 5
Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
Lyon PC. et al, (2017), Journal of Therapeutic Ultrasound, 5, 28 - 28
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
Petrella TM. et al, (2017), Eur J Cancer, 86, 115 - 124
QUALITY OF LIFE WITH WEEKLY, DOSE-DENSE VERSUS STANDARD CHEMOTHERAPY FOR OVARIAN CANCER IN THE ICON8 STUDY
Blagden SP. et al, (2017), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27, 1919 - 1919
QUALITY OF LIFE WITH WEEKLY, DOSE-DENSE VERSUS STANDARD CHEMOTHERAPY FOR OVARIAN CANCER IN THE ICON8 STUDY
Blagden SP. et al, (2017), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 27, 14 - 14
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Eyre TA. et al, (2017), British journal of haematology, 179, 471 - 479
Tasigna (nilotinib) in chronic myeloid leukemia treatment-free remission after nearly 2 years: an interview with Adam Mead
Mead A., (2017), FUTURE ONCOLOGY, 13, 2401 - 2404
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
Vlachodimitropoulou E. et al, (2017), Blood, 130, 1923 - 1933
Societal preferences for adjuvant melanoma health states: UK and Australia.
Middleton MR. et al, (2017), BMC Cancer, 17, 689 - 689
Development of HM-PRO, a haematology specific Patient-Reported Outcome Measure: content validation
Goswami P. et al, (2017), QUALITY OF LIFE RESEARCH, 26, 130 - 130
Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
Teoh EJ. et al, (2017), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 44, S633 - S634